XT
NAUT icon

XTX Topco’s Nautilus Biotechnolgy NAUT Stock Holding History

XTX Topco’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,608
Closed -$65.5K – 4174
2025
Q4 		$65.5K Sell
33,608
-12,116
-26% -$19.9K ﹤0.01% 2762
2025
Q3 		$38.6K Sell
45,724
-20,470
-31% -$15K ﹤0.01% 2214
2025
Q2 		$48K Buy
66,194
+30,641
+86% +$23K ﹤0.01% 2021
2025
Q1 		$30.6K Buy
+35,553
New +$52.8K ﹤0.01% 2077
2024
Q2 		– Sell
-11,594
Closed -$34.1K – 2258
2024
Q1 		$34.1K Buy
+11,594
New +$32.9K ﹤0.01% 1534

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco's NAUT Position: Q1 2026 in Review

XTX Topco sold out of Nautilus Biotechnolgy (NAUT) in Q1 2026, closing a stake of 33,608 shares — an estimated $65.5K sold.

XTX Topco first reported a position in NAUT in Q1 2024 and held it in 5 quarters. The position peaked at $65.5K in Q4 2025. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • XTX Topco reported no remaining Nautilus Biotechnolgy position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 33,608 Nautilus Biotechnolgy shares in Q1 2026, an estimated $65.5K.
  • XTX Topco first reported a position in Nautilus Biotechnolgy in Q1 2024 and held it in 5 quarters.
  • XTX Topco's Nautilus Biotechnolgy position peaked at $65.5K in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.